Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations

Pathogenic variants in dopa decarboxylase (DDC), the gene encoding the aromatic l-amino acid decarboxylase (AADC) enzyme, lead to a severe deficiency of neurotransmitters, resulting in neurological, neuromuscular, and behavioral manifestations clinically characterized by developmental delays, oculog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Himmelreich, Nastassja (VerfasserIn) , Montioli, Riccardo (VerfasserIn) , Garbade, Sven (VerfasserIn) , Kopesky, Jeffrey (VerfasserIn) , Elsea, Sarah H. (VerfasserIn) , Carducci, Carla (VerfasserIn) , Voltattorni, Carla B. (VerfasserIn) , Blau, Nenad (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 22 November 2022
In: Molecular genetics and metabolism
Year: 2022, Jahrgang: 137, Heft: 4, Pages: 359-381
ISSN:1096-7206
DOI:10.1016/j.ymgme.2022.11.003
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ymgme.2022.11.003
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1096719222004334
Volltext
Verfasserangaben:Nastassja Himmelreich, Riccardo Montioli, Sven F. Garbade, Jeffrey Kopesky, Sarah H. Elsea, Carla Carducci, Carla B. Voltattorni, Nenad Blau

MARC

LEADER 00000caa a2200000 c 4500
001 1831780216
003 DE-627
005 20230707001422.0
007 cr uuu---uuuuu
008 230123s2022 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ymgme.2022.11.003  |2 doi 
035 |a (DE-627)1831780216 
035 |a (DE-599)KXP1831780216 
035 |a (OCoLC)1389536098 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Himmelreich, Nastassja  |e VerfasserIn  |0 (DE-588)1067678972  |0 (DE-627)819077003  |0 (DE-576)426841123  |4 aut 
245 1 0 |a Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations  |c Nastassja Himmelreich, Riccardo Montioli, Sven F. Garbade, Jeffrey Kopesky, Sarah H. Elsea, Carla Carducci, Carla B. Voltattorni, Nenad Blau 
264 1 |c 22 November 2022 
300 |a 23 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar 12 November 2022, Artikelversion 22 November 2022 
500 |a Gesehen am 23.01.2023 
520 |a Pathogenic variants in dopa decarboxylase (DDC), the gene encoding the aromatic l-amino acid decarboxylase (AADC) enzyme, lead to a severe deficiency of neurotransmitters, resulting in neurological, neuromuscular, and behavioral manifestations clinically characterized by developmental delays, oculogyric crises, dystonia, and severe neurologic dysfunction in infancy. Historically, therapy has been aimed at compensating for neurotransmitter abnormalities, but response to pharmacologic therapy varies, and in most cases, the therapy shows little or no benefit. A novel human DDC gene therapy was recently approved in the European Union that targets the underlying genetic cause of the disorder, providing a new treatment option for patients with AADC deficiency. However, the applicability of human DDC gene therapy depends on the ability of laboratories and clinicians to interpret the results of genetic testing accurately enough to diagnose the patient. An accurate interpretation of genetic variants depends in turn on expert-guided curation of locus-specific databases. The purpose of this research was to identify previously uncharacterized DDC variants that are of pathologic significance in AADC deficiency as well as characterize and curate variants of unknown significance (VUSs) to further advance the diagnostic accuracy of genetic testing for this condition. DDC variants were identified using existing databases and the literature. The pathogenicity of the variants was classified using modified American College of Medical Genetics and Genomics/Association for Molecular Pathology/Association for Clinical Genomic Science (ACMG-AMP/ACGS) criteria. To improve the current variant interpretation recommendations, in silico variant interpretation tools were combined with structural 3D modeling of protein variants and applied comparative analysis to predict the impact of the variant on protein function. A total of 422 variants were identified (http://biopku.org/home/pnddb.asp). Variants were identified on nearly all introns and exons of the DDC gene, as well as the 3′ and 5′ untranslated regions. The largest percentage of the identified variants (48%) were classified as missense variants. The molecular effects of these missense variants were then predicted, and the pathogenicity of each was classified using a number of variant effect predictors. Using ACMG-AMP/ACGS criteria, 7% of variants were classified as pathogenic, 32% as likely pathogenic, 58% as VUSs of varying subclassifications, 1% as likely benign, and 1% as benign. For 101 out of 108 reported genotypes, at least one allele was classified as pathogenic or likely pathogenic. In silico variant pathogenicity interpretation tools, combined with structural 3D modeling of variant proteins and applied comparative analysis, have improved the current DDC variant interpretation recommendations, particularly of VUSs. 
650 4 |a AADC 
650 4 |a dopa decarboxylase 
650 4 |a gene variant curation 
650 4 |a locus-specific database 
650 4 |a neurotransmitter deficiency 
650 4 |a pathogenicity 
700 1 |a Montioli, Riccardo  |e VerfasserIn  |4 aut 
700 1 |a Garbade, Sven  |d 1971-  |e VerfasserIn  |0 (DE-588)129234362  |0 (DE-627)707186889  |0 (DE-576)297554263  |4 aut 
700 1 |a Kopesky, Jeffrey  |e VerfasserIn  |4 aut 
700 1 |a Elsea, Sarah H.  |e VerfasserIn  |4 aut 
700 1 |a Carducci, Carla  |e VerfasserIn  |4 aut 
700 1 |a Voltattorni, Carla B.  |e VerfasserIn  |4 aut 
700 1 |a Blau, Nenad  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Molecular genetics and metabolism  |d Orlando, Fla. : Academic Press, 1998  |g 137(2022), 4, Seite 359-381  |h Online-Ressource  |w (DE-627)268125260  |w (DE-600)1471393-7  |w (DE-576)106869493  |x 1096-7206  |7 nnas  |a Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations 
773 1 8 |g volume:137  |g year:2022  |g number:4  |g pages:359-381  |g extent:23  |a Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations 
856 4 0 |u https://doi.org/10.1016/j.ymgme.2022.11.003  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1096719222004334  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230123 
993 |a Article 
994 |a 2022 
998 |g 129234362  |a Garbade, Sven  |m 129234362:Garbade, Sven  |d 910000  |d 910500  |e 910000PG129234362  |e 910500PG129234362  |k 0/910000/  |k 1/910000/910500/  |p 3 
998 |g 1067678972  |a Himmelreich, Nastassja  |m 1067678972:Himmelreich, Nastassja  |d 910000  |d 910500  |e 910000PH1067678972  |e 910500PH1067678972  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1831780216  |e 4250672565 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"22 November 2022","dateIssuedKey":"2022"}],"language":["eng"],"recId":"1831780216","note":["Online verfügbar 12 November 2022, Artikelversion 22 November 2022","Gesehen am 23.01.2023"],"name":{"displayForm":["Nastassja Himmelreich, Riccardo Montioli, Sven F. Garbade, Jeffrey Kopesky, Sarah H. Elsea, Carla Carducci, Carla B. Voltattorni, Nenad Blau"]},"person":[{"given":"Nastassja","role":"aut","display":"Himmelreich, Nastassja","family":"Himmelreich"},{"family":"Montioli","display":"Montioli, Riccardo","role":"aut","given":"Riccardo"},{"display":"Garbade, Sven","family":"Garbade","given":"Sven","role":"aut"},{"role":"aut","given":"Jeffrey","family":"Kopesky","display":"Kopesky, Jeffrey"},{"role":"aut","given":"Sarah H.","family":"Elsea","display":"Elsea, Sarah H."},{"role":"aut","given":"Carla","family":"Carducci","display":"Carducci, Carla"},{"given":"Carla B.","role":"aut","display":"Voltattorni, Carla B.","family":"Voltattorni"},{"role":"aut","given":"Nenad","family":"Blau","display":"Blau, Nenad"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"pubHistory":["63.1998 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Molecular genetics and metabolism","title_sort":"Molecular genetics and metabolism"}],"id":{"zdb":["1471393-7"],"issn":["1096-7206"],"eki":["268125260"]},"origin":[{"publisherPlace":"Orlando, Fla.","dateIssuedKey":"1998","publisher":"Academic Press","dateIssuedDisp":"1998-"}],"part":{"issue":"4","pages":"359-381","year":"2022","text":"137(2022), 4, Seite 359-381","volume":"137","extent":"23"},"language":["eng"],"note":["Gesehen am 14.02.20"],"recId":"268125260","disp":"Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendationsMolecular genetics and metabolism"}],"title":[{"title":"Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations","title_sort":"Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations"}],"physDesc":[{"extent":"23 S."}],"id":{"eki":["1831780216"],"doi":["10.1016/j.ymgme.2022.11.003"]}} 
SRT |a HIMMELREICSPECTRUMOF2220